Mesoblast Limited (AU:MSB) has released an update.
JPMorgan Chase & Co. and its affiliates have emerged as substantial shareholders in Mesoblast Ltd, acquiring a 5.76% voting power through the possession of 65,725,661 ordinary shares. The financial giant’s various subsidiaries and branches have engaged in multiple transactions, including securities lending agreements and proprietary purchases, to achieve this significant stake in the biotechnology company.
For further insights into AU:MSB stock, check out TipRanks’ Stock Analysis page.
